【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 12
1.2 List of Figures 23
2 Introduction 28
2.1 Catalyst 28
2.2 Related Reports 29
3 Industry Overview 30
3.1 Emergence of Companion Diagnostics 30
3.1.1 Definition of Companion Diagnostics 30
3.1.2 Changing Face of Medicine 31
3.1.3 Definitions of Companion and Personalized Diagnostics 33
3.2 Disease Applications 35
3.2.1 Breast Cancer 35
3.2.2 Colorectal Cancer 38
3.2.3 Melanoma 40
3.2.4 Non-Small Cell Lung Cancer 41
3.3 Companion Diagnostics Technologies 43
3.3.1 Immunochemical Techniques 43
3.3.2 Nucleic Acid Testing 45
3.3.3 Emerging Technologies 52
3.4 Companion Diagnostics Development 54
3.4.1 Economic Value of a Companion Diagnostic 54
3.4.2 When to Develop a Companion Diagnostic Test 55
3.4.3 Strategy 58
3.4.4 Selection of Partner 59
3.4.5 Biomarker Discovery 61
3.5 Clinical Outcomes 62
3.5.1 Role of Companion Diagnostics in Disease Treatment 62
3.5.2 Companion Diagnostic Test Applications 63
3.6 Testing Trends 64
3.6.1 US 64
3.6.2 France 75
3.6.3 Germany 85
3.6.4 Italy 92
3.6.5 Spain 100
3.6.6 UK 106
3.6.7 Japan 120
3.6.8 Brazil 129
3.6.9 China 135
3.6.10 India 143
3.7 Market Access 150
3.7.1 Overview 150
3.7.2 US 150
3.7.3 5EU 154
3.7.4 Japan 165
3.7.5 Brazil 167
3.7.6 China 169
3.7.7 India 172
3.8 Regulatory Issues and Recalls 173
3.8.1 Dako FDA Warning Letter 173
3.8.2 HercepTest Recall 174
3.8.3 Cobas KRAS Test Recall 174
3.8.4 Cobas BRF V600E Test Recall 174
3.8.5 Leica Bond HER2 IHC System 174
3.9 Reimbursement of Companion Diagnostic Tests 175
3.9.1 US 175
3.9.2 Europe 180
3.9.3 APAC 192
3.9.4 South America 197
3.10 M&A, Key Partnerships 199
3.10.1 Significant Mergers and Acquisitions 201
3.10.2 Recent Partnerships 201
3.11 Economic Impact 207
3.11.1 Cost Effectiveness of Companion Diagnostics 207
3.11.2 Cost Effectiveness of Companion Diagnostics: Healthcare Provider Perspective 208
3.12 Market Drivers 214
3.12.1 Driver: Increasing Healthcare Pressures 214
3.12.2 Driver: Adverse Economic Pressures 215
3.12.3 Driver: Availability of New Technologies 215
3.12.4 Driver: FDA Regulatory Changes 216
3.12.5 Driver: Need to Improve Drug Development Processes 216
3.12.6 Driver: Increasing Cancer Incidence 217
3.12.7 Driver: Accelerating Demand for Targeted Therapies 217
3.13 Market Barriers 219
3.13.1 Barrier: Reimbursement Difficulties 219
3.13.2 Barrier: Loss of Indication 219
3.13.3 Barrier: Emergence of Biosimilar Therapies 220
3.13.4 Barrier: Competition with Laboratory-Developed Tests 221
3.13.5 Barrier: Emergence of Next-Generation Gene Sequencing 222
3.13.6 Barrier: Lack of Laboratory Choice in Instrument Selection 223
3.13.7 Barrier: Lack of Patient Awareness about Companion Diagnostic Tests 224
3.13.8 Barrier: Physician Resistance to New Companion Diagnostic Tests 225
4 Competitive Assessment 227
4.1 Overview 227
4.2 Techniques in Use by Currently Marketed Products 227
4.2.1 Immunohistochemistry 227
4.2.2 Fluorescence In Situ Hybridization 227
4.2.3 Polymerase Chain Reaction 228
4.3 Competitive Analysis 228
4.3.1 Breast Cancer Companion Diagnostic Tests 228
4.3.2 Colorectal Cancer Companion Diagnostic Tests 257
4.3.3 Melanoma Companion Diagnostic Tests 267
4.3.4 Non-Small Cell Lung Cancer Companion Diagnostic Tests 273
5 Unmet Needs 290
5.1 Need for Improved Cancer Treatments 290
5.2 Need for Objective Tests 290
5.3 Need for High-Throughput Tests 292
5.4 Certainty of Reimbursement 293
5.5 Amount and Type of Tissue Needed for Test 294
5.6 Who Should be Tested? 297
5.7 Test Accuracy 302
5.8 Increasing Test Complexity and Increased Process Failure 305
6 Pipeline Products 306
6.1 Overview 306
6.2 Pipeline by Phase of Development 308
6.3 Pipeline Product Profiles 310
6.3.1 Breast Cancer Companion Diagnostic Tests 310
6.3.2 Colorectal Cancer Companion Diagnostic Tests 318
6.3.3 Melanoma Companion Diagnostic Tests 324
6.3.4 Non-Small Cell Lung Cancer Companion Diagnostic Tests 331
7 Clinical Trials to Watch 347
7.1 Overview 347
7.2 Key Clinical Trials Utilizing Pipeline Companion Diagnostic Tests Linked to Specific Drug Therapies 351
8 Current and Future Players 352
8.1 Trends in Corporate Strategy 352
8.1.1 Companion Diagnostics Business Models 352
8.2 Company Profiles 353
8.2.1 Pharmaceutical/Therapy Companies Developing Companion Diagnostic Tests 353
8.2.2 Diagnostics Companies Developing Companion Diagnostic Tests (in Partnership with Pharmaceutical Companies) 409
9 Market Outlooks 492
9.1 By Market Segment 492
9.1.1 Breast Cancer Companion Diagnostic Tests 492
9.1.2 Colorectal Cancer Companion Diagnostic Tests 493
9.1.3 Melanoma Companion Diagnostic Tests 496
9.1.4 Non-Small Cell Lung Cancer Companion Diagnostic Tests 498
9.1.5 Technique 504
9.2 By Geography 507
9.2.1 10 Major Markets Overview 507
9.2.2 US 509
9.2.3 France 510
9.2.4 Germany 512
9.2.5 Italy 514
9.2.6 Spain 516
9.2.7 UK 518
9.2.8 Japan 520
9.2.9 Brazil 523
9.2.10 China 525
9.2.11 India 527
10 Appendix 530
10.1 Bibliography 530
10.2 Abbreviations 582
10.3 Report Methodology 584
10.3.1 Coverage 584
10.3.2 Secondary Research 585
10.3.3 Forecasting Methodology 585
10.4 Physicians Included in this Study 587
10.5 About the Authors 589
10.5.1 Andrew Thompson, Ph.D., Senior Analyst, In Vitro Diagnostics 589
10.5.2 Derek Archila, MBA, Lead Analyst, Medical Devices 589
10.5.3 Bonnie Bain, PhD, Global Head of Healthcare 590
10.6 Disclaimer 591
【レポート販売概要】
■ タイトル:腫瘍向けコンパニオン診断:グローバル市場分析と予測■ 英文:MediPoint: Companion Diagnostic Tests in Oncology - Global Analysis and Market Forecasts
■ 発行日:2014年5月5日
■ 調査会社:GlobalData
■ 商品コード:GDME0189MAR
■ 調査対象地域:グローバル
- エアロゲルの世界市場:シリカエアロゲル、ポリマーエアロゲル、カーボンエアロゲルAerogel is an advanced high-performance insulation material that has high load-bearing capacity with high resistance to thermal, flame, moisture, sound, and weather. These unique properties find applications for aerogel, such as oil & gas, construction, automotive, marine, & aerospace, performance coating, day-lighting & LVHS among others. The market for aerogel is estimated to grow on account of …
- ロシアの原子力発電産業分析:Analyzing Nuclear Power in RussiaRussia has substantial resources of uranium, with about 10% of world’s assured resources plus inferred resources up to US$ 130/kg - 487,000 tons. Exploration expenditure has nearly doubled in two years to about US$ 52 million in 2010. Plans announced in 2006 for 28,600 t/yr U3O8 output by 2020, 18,000t of this from Russia and the balance from Kazakhstan, Ukraine, Uzbekistan and Mongolia have since …
- Cabot Oil & Gas Corporation:石油・ガスの開発・生産動向及びコスト分析– Q1, 2013Cabot Oil & Gas Corporation Oil & Gas Exploration and Production Operations and Cost Analysis – Q1, 2013 Summary Cabot Oil & Gas Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an esse …
- パンおよびロールの世界市場2016-2020About Bread and Rolls The global bread and rolls market is expected to grow steadily during the forecast period. Europe dominated the market in 2015, followed by APAC and North America. Artisanal bread and rolls as a product category under global bread and rolls market accounted for the majority of the sales in 2015. Technavio’s analysts forecast the global bread and rolls market to grow at a CAGR …
- グローバル・マネー・ローンダリング対策(AML)ソフトウェア市場(2014-2018)About Anti-money Laundering (AML) Software AML software is used by financial institutions to detect suspicious transactions and analyze customer data. AML software operates under various categories including currency transaction report, customer identity management, transaction monitoring systems, and compliance software. AML solutions provide real-time alerts and tools for financial enterprises t …
- 事業提携・ライセンシング・投資・M&A動向(四半期別):Q1 2013Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q1 2013 Summary GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q1 2013” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report provides …
- スマート照明の世界市場:蛍光ランプ、LEDランプ、HIDランプSmart lighting is an advanced technology in lighting that makes use of intelligent lighting control systems to manage the illumination of a particular area. Smart lighting market is growing at a phenomenal rate and main drivers for this growth are energy efficiency, development in electronics and sensor technology, phase out of incandescent lamps, favorable government policies and evolution of nov …
- Pace Oil & Gas Ltd.:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Pace Oil & Gas Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Pace Oil & Gas Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for …
- 防湿絶縁コーティングの世界市場:アクリル塗料、エポキシ塗料、ウレタン塗料、シリコーン塗料、パリレン塗料The global conformal coatings market is estimated to reach USD 12.28 Billion by 2021, registering a CAGR of 4.7% between 2016 and 2021. The market is driven by increasing demand for conformal coatings in emerging markets and high demand from printed circuit boards in electronics and automotive & transportation industries. Conformal coatings have unique properties, such as high resistance to dust, …
- 腎臓及び泌尿器科用医療機器の世界市場2019-2023About this market The emergence of innovative technologies is one of the key factors expected to foster the nephrology and urology devices market growth in the forthcoming years. Vendors are increasing their R&D efforts in introducing technologically advanced devices. In addition, these advances will also help in developing user-friendly, light-weight, and at-home HD machines with connectivity fea …
- 収益サイクル管理 (RCM) の世界市場予測(~2021):製品別(統合型RCM、独立型RCM)、構成要素別、導入別、需要先別、地域別The global revenue cycle management market is projected to reach USD 80.56 Billion by 2021 from USD 45.52 Billion in 2016, growing at a CAGR of 12.1% during the forecast period. Growth in the market is driven by the regulatory compliance encouraging the use of RCM solutions, government support, increasing number of patients, and process improvements in healthcare organizations brought about by RCM …
- リクライニングソファの世界市場2016-2020About Recliner Sofa A recliner sofa is a category of upholstery seaters that allow users to adjust the back- and leg rest to suit their preference. The key rationale behind the development of the mechanism that allows the conversion of the upright position of recliners to a reclined position is to increase the comfort level of consumers. Technavio’s analysts forecast the global recliner sofas mark …
- 高度圧力保護システム(HIPPS)の世界市場2017-2021About high-integrity pressure protection systemHIPPS is a type of safety instrumented system (SIS) that is used to safeguard a process to prevent a catastrophic release of flammable, toxic or explosive chemicals. Traditionally, in industrial plants, flare or relief systems are used for burning off flammables gases that are released through pressure relief valves during unplanned over-pressurizatio …
- Mobile Applications and Widgets: Portable Applications on Mobile Platforms Third EditionMobile Applications and Widgets: Portable Applications on Mobile Platforms, Third Edition provides a complete understanding of the mobile software marketplace. The reader will learn about mobile applications from the inception and evolution of applications on mobile platforms, to current market trends. The state of the current market is defined through current market statistical data, financial an …
- 手術前計画ソフトウェアの世界市場:種類別(オフプレミス、オンプレミス)、用途別(整形外科[一般的な整形外科手術、変形矯正、骨折管理、および関節再建]、脳神経外科、歯科および歯列矯正用、およびその他)、エンドユーザー別(病院、整形外科、リハビリテーションセンター)Surgical preoperative planning software is a specialized form of software that manages different surgeries such as neurology and orthopedic surgeries. Different modalities such as neurology, dental & orthopedic surgeries, including joint, reconstruction, and deformity correction can be planned accordingly with the aid of this software. In addition, it creates digitally accurate data that can be ea …